Part 1 of phase-1 Covaxin trial shows encouraging results: Rohtak PGI Doctor

Name: Part 1 of phase-1 Covaxin trial shows encouraging results: Rohtak PGI Doctor
Uploaded: 2020-07-26T03:55:13+00:00
Duration: P106S
Description: As the world is scrambling to develop a COVID-19 vaccine, Principal Investigator of vaccine trial team at Rohtak PGI Doctor Savita Verma informed that part 1 of

Video Credit: ANI - Duration: 01:46s - Published on July 26, 2020

Part 1 of phase-1 Covaxin trial shows encouraging results: Rohtak PGI Doctor

As the world is scrambling to develop a COVID-19 vaccine, Principal Investigator of vaccine trial team at Rohtak PGI Doctor Savita Verma informed that part 1 of phase-1 of Covaxin trial is completed and it shows encouraging results.

"Part 1 of phase-1 of vaccine trial (Covaxin) completed.

50 people across India were administered the vaccine, results encouraging.

6 people were administered vaccine today under part 2 of phase-1," said Verma.

0 shares	Share Tweet Save Post Send

Related videos from verified sources

Covid: First part of phase-1 Covaxin human trial completed at PGI Rohtak [Video]

Covid: First part of phase-1 Covaxin human trial completed at PGI Rohtak

The first part of phase-1 of Covaxin human trial completed on Saturday. The trial was conducted at Post-Graduate Institute (PGI) of Medical Sciences, Rohtak, said Dr Savita Verma, principal..

Credit: HT Digital Content Duration: 02:37Published on July 26, 2020

Phase 3 Coronavirus Vaccine Trial To Go Ahead At UIC [Video]

Phase 3 Coronavirus Vaccine Trial To Go Ahead At UIC

Promising results were announced Tuesday for a possible COVID-19 vaccine made by Moderna, and Phase 3 trials will be held in part at the University of Illinois at Chicago. CBS 2's Charlie De Mar..

Credit: CBS 2 Chicago Duration: 01:56Published on July 15, 2020

Part 1 of phase-1 Covaxin trial shows encouraging results: Rohtak PGI Doctor

You Might Like

Related videos from verified sources